Robot surgeons take on gallbladder cancer in global trial
NCT ID NCT06246448
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study compares robotic-assisted surgery to traditional open surgery for gallbladder cancer. About 94 patients will be randomly assigned to one of the two procedures. The main goal is to see which approach helps patients recover faster after surgery, measured by pain control, mobility, and ability to eat. Researchers will also look at hospital stay length, complications, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Robotic-assisted surgery
- What this could lead to
- If successful, robotic surgery could lead to faster recovery and shorter hospital stays for gallbladder cancer patients.
- What could go wrong
- This is a relatively small trial (94 participants) and results may not apply to all patients. Robotic surgery may not improve outcomes or could have higher costs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GALL BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Region Stockholm
RECRUITINGStockholm, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat GI cancers?
- Zapping spreading tumors could extend life on current cancer drugs
- New drug combo tested for tough bile duct cancers
- New combo therapy shows promise for Tough-to-Treat bile duct cancer
- Blood tests and patient surveys could improve bile duct cancer monitoring
- CRISPR-Engineered immune cells take on stomach and colon cancers